SEC Comment Letter 0000000000-24-009771 to Medical Care Technologies Inc. (MDCE) (CIK 0001404593) (MDCE)
Medical Care Technologies Inc. (MDCE) (CIK 0001404593)
Date: Aug. 27, 2024 · CIK: 0001404593 · Accession: 0000000000-24-009771
AI Filing Summary & Sentiment
File numbers found in text: 024-12484
Show Raw Text
August 27, 2024
Marshall Perkins III
Chief Executive Officer
Medical Care Technologies Inc.
1910 S Stapley Drive, Suite 221
Mesa, AZ 85204
Re:Medical Care Technologies Inc.
Offering Statement on Form 1-A
Filed August 9, 2024
File No. 024-12484
Dear Marshall Perkins III:
We have reviewed your offering statement and have the following comment.
Please respond to this letter by amending your offering statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response. After
reviewing any amendment to your offering statement and the information you provide in response
to this letter, we may have additional comments.
Offering Statement on Form 1-A
Risk Factors, page 11
1.Please revise to add a risk factor discussing the company's past record regarding not filing
periodic reports in a timely fashion or being a delinquent filer and the associated risks for
investors.
We will consider qualifying your offering statement at your request. In connection with
your request, please confirm in writing that at least one state has advised you that it is prepared to
qualify or register your offering. If a participant in your offering is required to clear its
compensation arrangements with FINRA, please have FINRA advise us that it has no objections
to the compensation arrangements prior to qualification.
We remind you that the company and its management are responsible for the accuracy and
adequacy of their disclosures, notwithstanding any review, comments, action or absence of action
by the staff.
August 27, 2024
Page 2
Please contact Scott Anderegg at 202-551-3342 or Donald Field at 202-551-3680 with any
other questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services